70 related articles for article (PubMed ID: 1964819)
1. Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.
Thyagarajan B; Potian JG; Garcia CC; Hognason K; Capková K; Moe ST; Jacobson AR; Janda KD; McArdle JJ
Neuropharmacology; 2010 Jun; 58(8):1189-98. PubMed ID: 20211192
[TBL] [Abstract][Full Text] [Related]
2. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
Minic J; Chatonnet A; Krejci E; Molgó J
Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic M(2) muscarinic receptors are involved in controlling the kinetics of ACh release at the frog neuromuscular junction.
Slutsky I; Silman I; Parnas I; Parnas H
J Physiol; 2001 Nov; 536(Pt 3):717-25. PubMed ID: 11691867
[TBL] [Abstract][Full Text] [Related]
4. Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.
Machamer JB; Vazquez-Cintron EJ; O'Brien SW; Kelly KE; Altvater AC; Pagarigan KT; Dubee PB; Ondeck CA; McNutt PM
Mol Med; 2022 Jun; 28(1):61. PubMed ID: 35659174
[TBL] [Abstract][Full Text] [Related]
5. Magnesium Sulfate and Its Versatility in Anesthesia: A Comprehensive Review.
Dahake JS; Verma N; Bawiskar D
Cureus; 2024 Mar; 16(3):e56348. PubMed ID: 38633961
[TBL] [Abstract][Full Text] [Related]
6. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.
Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
J Physiol; 2013 May; 591(10):2747-62. PubMed ID: 23440963
[TBL] [Abstract][Full Text] [Related]
7. Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.
Lindquist S; Stangel M
Neuropsychiatr Dis Treat; 2011; 7():341-9. PubMed ID: 21822385
[TBL] [Abstract][Full Text] [Related]
8. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
Flink MT; Atchison WD
J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
[TBL] [Abstract][Full Text] [Related]
9. Action of alpha-dendrotoxin on K+ currents in nerve terminal regions of axons in rat olfactory cortex.
McGivern J; Scholfield CN; Dolly JO
Br J Pharmacol; 1993 Jun; 109(2):535-8. PubMed ID: 8358554
[TBL] [Abstract][Full Text] [Related]
10. Transmitter-mediated local contracture of the endplate region of the focally innervated mouse diaphragm treated with anticholinesterase.
Hong SJ; Chang CC
Br J Pharmacol; 1993 Aug; 109(4):1178-85. PubMed ID: 8104646
[TBL] [Abstract][Full Text] [Related]
11. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
Plomp JJ; van Kempen GT; Molenaar PC
J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
[TBL] [Abstract][Full Text] [Related]
12. Physiological and regenerative acetylcholine release from motor nerve: differential inhibitions by vesamicol and omega-agatoxin IVA.
Hong SJ; Lee SH; Chang CC
Neuroscience; 1995 Jul; 67(1):169-75. PubMed ID: 7477897
[TBL] [Abstract][Full Text] [Related]
13. Reversal by cysteine of the cadmium-induced block of skeletal neuromuscular transmission in vitro.
Braga MF; Rowan EG
Br J Pharmacol; 1992 Sep; 107(1):95-100. PubMed ID: 1330169
[TBL] [Abstract][Full Text] [Related]
14. The actions of tetraethylammonium at the neuromuscular junction.
Elliott RC
Gen Pharmacol; 1982; 13(1):11-4. PubMed ID: 7037528
[TBL] [Abstract][Full Text] [Related]
15. The neuromuscular effects of lignocaine.
Wali FA
Gen Pharmacol; 1984; 15(3):197-200. PubMed ID: 6376275
[TBL] [Abstract][Full Text] [Related]
16. Facilitation by 3,4-diaminopyridine of regenerative acetylcholine release from mouse motor nerve.
Hong SJ; Chang CC
Br J Pharmacol; 1990 Dec; 101(4):793-8. PubMed ID: 1964819
[TBL] [Abstract][Full Text] [Related]
17. Antagonism by tubocurarine and verapamil of the regenerative acetylcholine release from mouse motor nerve.
Hong SJ; Chang CC
Eur J Pharmacol; 1989 Mar; 162(1):11-7. PubMed ID: 2721560
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
